Please Wait...

Iron

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Iron is one of the most important nonorganic molecule for most forms of life. Almost all cells employ iron for fundamental activities such as energy metabolism and oxygen transport. The three main source of iron are the dietary absorption in the duodenum, the release of recycled iron from macrophages and the release of stored iron from hepatocytes (Kohgo et al., 2008). At the same time, iron excess is toxic due to its capacity to generate reactive oxygen species, underlining the importance of iron homeostasis. Iron balance in the human body is mainly regulated at the absorption step as there is no physiological mechanism for iron excretion. Four main proteins are regulating the iron balance: transferrin, ferritin, ferroportin and hepcidin (Wang and Pantopoulos, 2011). Within cells, iron is stored in cytoplasmic ferritin and can be used in period of high iron demand. Iron exits from cells via the iron exporter ferroportin, a transmembrane protein, and is transported into the bloodstream by transferrin. Hepcidin is able to inhibit iron entry into the plasma compartment by promoting the degradation of ferroportin (Nemeth et al., 2004). Disruptions in iron homeostasis are linked to numerous disorders, including cardiovascular and metabolic diseases and cancer.

Bioclinica Lab employs a colorimetric method performed in an automated platform for the measurement of iron in human serum.

Kohgo, Y., Ikuta, K., Ohtake, T., Torimoto, Y., and Kato, J. (2008). Body iron metabolism and pathophysiology of iron overload. Int. J. Hematol. 88, 7–15.

Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T., and Kaplan, J. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093.

Wang, J., and Pantopoulos, K. (2011). Regulation of cellular iron metabolism. Biochem. J. 434, 365–381.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join Bioclinica in a live #Xtalks webinar 10/31 exploring challenges & benefits of different sourcing models to man… https://t.co/kRYNc1Z3gj
bioclinica (3 hours ago)
Bioclinica contributions toward advancement of #Alzheimer's disease research & therapies showcased in 8 different s… https://t.co/j96UN9568o
bioclinica (9 hours ago)
Bioclinica’s Joby John reflects on the #SCDM2018 Annual Conference & being a part a thriving community of clinical… https://t.co/c70gH5kJo9
bioclinica (Yesterday)
RT @bioclinica: Our own Jeff Heilbraun is in Tokyo nxt wk to lead a discussion at DIA’s Cardiac Safety Workshop in Japan. Jeff will give an…
bioclinica (Yesterday)
RT @Xtalks: Trends in #SitePayments: Insight into How CROs Can Gain a Competitive Edge This webinar will focus on the latest market researc…
bioclinica (Yesterday)
Great connecting w @bioclinica clients Odonate Therapeutics, Eisai, & PCI Biotech, at #ESMO18 #oncology… https://t.co/4wKrLof8e6
bioclinica (Yesterday)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner